Showing results (1-10 of 431) with videos related to
Sort By:
Pageof 44
Clinical Pharmacology and Therapeutics|May 1, 1992
Long-term weight control study. VII (weeks 0 to 210). Serum lipid changesM Weintraub, P R Sundaresan, B SchusterClinical Pharmacology and Therapeutics|May 1, 1992
Long-term weight control study. III (weeks 104 to 156). An open-label study of dose adjustment of fenfluramine and phentermineM Weintraub, P R Sundaresan, B Schuster, et al.Clinical Pharmacology and Therapeutics|May 1, 1992
Long-term weight control study. V (weeks 190 to 210). Follow-up of participants after cessation of medicationM Weintraub, P R Sundaresan, B Schuster, et al.Clinical Pharmacology and Therapeutics|May 1, 1992
Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placeboM Weintraub, P R Sundaresan, M Madan, et al.Clinical Pharmacology and Therapeutics|May 1, 1992
Long-term weight control study. IV (weeks 156 to 190). The second double-blind phaseM Weintraub, P R Sundaresan, B Schuster, et al.Clinical Pharmacology and Therapeutics|May 1, 1986
Phenylpropanolamine OROS (Acutrim) vs. placebo in combination with caloric restriction and physician-managed behavior modificationM Weintraub, G Ginsberg, E C Stein, et al.Clinical Pharmacology and Therapeutics|May 1, 1992
Long-term weight control study. VI. Individual participant response patternsM Weintraub, P R Sundaresan, C CoxClinical Pharmacology and Therapeutics|May 1, 1992
Long-term weight control study. II (weeks 34 to 104). An open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exerciseM Weintraub, P R Sundaresan, B Schuster, et al.Clinical Pharmacology and Therapeutics|April 1, 1979
Methodology for demonstrating sustained efficacy of hypnotics: a comparative study of triazolam and flurazepamP R Sundaresan, W M Wardell, M Weintraub, et al.Clinical Pharmacology and Therapeutics|March 1, 1985
Platelet alpha-2 adrenoceptors and the menstrual cycleP R Sundaresan, M K Madan, S L Kelvie, et al.Pageof 44